Imaging News

Diltiazem vs. placebo for coronary vasomotor dysfunction in patients with angina and nonobstructive CAD.

Valve-in-valve transcatheter aortic valve replacement with a self-expanding vs. balloon-expandable valve was associated with improved valve hemodynamics and no between-group differences in clinical outcomes, researchers reported at EuroPCR.

A next-generation transcatheter aortic valve replacement system was associated with less paravalvular aortic regurgitation compared with an earlier version, researchers reported at EuroPCR.

WASHINGTON — In the ADAPT-TAVR trial of patients who had transcatheter aortic valve replacement and no indication for long-term anticoagulation, edoxaban did not improve leaflet thrombosis compared with dual antiplatelet therapy.

Cardiac MRI demonstrated superiority to transthoracic echocardiography in identifying elevated left ventricular filling pressure among patients with suspected HF presenting with breathlessness, researchers reported.

The FDA approved magnetic resonance conditional labeling for an implantable neurostimulator HF device, allowing patients with the device to safely undergo MRI, according to a press release from CVRx.

Oral calcium supplementation with or without vitamin D was associated with lower survival and a greater need for aortic valve replacement among older patients with mild to moderate aortic stenosis, researchers reported.

The Society for Cardiovascular Angiography and Interventions published its recommendations for percutaneous placement of large-bore arterial sheaths and devices specifically via transaxillary arterial access.

WASHINGTON — Sodium thiosulfate, administered before and after reperfusion for STEMI, did not improve infarct size between 4 months and 2 years compared with placebo, a speaker reported.

Arterys announced it has added several new elements to its artificial intelligence-enhanced cardiac MRI platform and an additional FDA clearance for two quantification modules.